FinVolution Group Reports Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results

Full Year 2025 Revenue reached RMB13.6 billion, up 3.8% year-over-year- -Full Year 2025 International Transaction Volume reached RMB14.0 billion, up 38.6% year-over-year- - ...

Tencent Music Entertainment Group Announces Fourth Quarter and Full-Year 2025 Unaudited Financial Results

Tencent Music Entertainment Group ("TME," or the "Company") (NYSE: TME and HKEX: 1698), the leading online music and ...
Scientific Research Publishing

A Multimodal Machine-Learning Framework for Predicting Lithium-Associated Renal Dysfunction from Synthetic Biomarker Trajectories ()

Long-term lithium therapy remains the most effective maintenance treatment for bipolar disorder, yet it poses a significant risk of progressive renal impairment in a subset of patients. Early ...
Scientific Research Publishing

Moving beyond ROI: A Strategic Governance Framework for Value Realization in Healthcare Technology Investments ()

The systemic failure to optimize multibillion-dollar annual investments in healthcare technology poses a significant threat to organizational sustainability and patient equity. Healthcare information ...
EuropaWire

AstraZeneca’s Imfinzi Regimen Approved in the European Union for Early-Stage Gastric and Gastroesophageal Junction Cancers

AstraZeneca has received approval from the European Commission for the use of Imfinzi (durvalumab) in combination with FLOT chemotherapy as a perioperative treatment for adults with resectable ...